ArticleBMC pulmonary medicine2026
Efficacy and economic impact of a WeChat-based integrated care model for pulmonary rehabilitation in COPD: a retrospective propensity score matched study.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPulmonary rehabilitation is essential for patients with chronic obstructive pulmonary disease (COPD). However, pulmonary rehabilitation is often underutilized in COPD patients, primarily due to fragmented healthcare delivery systems and suboptimal patient compliance, contributing to recurrent hospital readmissions with a substantial economic healthcare system burden. We aimed to evaluate the impact of a novel WeChat-facilitated hospital-community-family integrated rehabilitation model on clinical outcomes and healthcare resource utilization in moderate to severe COPD patients.
methodsA retrospective study involved eligible COPD patients discharged between January 2022 and January 2024. Patient information, including demographics, residence, marriage, weight, height, medical history, COPD stage, treatment regimens, and baseline pulmonary function, were collected. Propensity score matching was applied and patients were assigned into the integrated care group (a WeChat-based digital hub: hospital-community-family integrated care model) or traditional care group (standard pulmonary rehabilitation) at a 1:1 ratio. Pulmonary function (forced expiratory volume in one second, FEV1), quality of life (COPD assessment test, CAT), and exercise capacity (6-min walk test, 6MWT) six months after the hospital discharge, as well as healthcare utilization (readmission rates) and a preliminary economic assessment, were compared between two groups.
resultsA total of 253 patients were reviewed. After propensity score matching, 87 patients were included in each group. Inter-group baseline characteristics were comparable. Six months following rehabilitation, the integrated care group demonstrated significantly better outcomes in FEV₁ (53.2 ± 17.8 vs. 47.4 ± 19.8%), CAT score (9.1 ± 3.5 vs. 12.6 ± 4.1), and 6MWT (385.0 ± 33.7 vs. 374.1 ± 34.2 m) compared with the traditional care group. Readmission rates were significantly lower in the integrated care group (11.5% vs. 28.7%, P = 0.005). The integrated model resulted in a net economic benefit of Chinese Yuan 115,104 over six months, with a per-patient saving of Chinese Yuan 1,323.03.
conclusionsThe WeChat-based digital hub model could improve lung function, enhance quality of life, reduce healthcare utilization costs, and lower healthcare cost, with greater exercise capacity in patients with moderate or severe COPD following hospital discharge. This study presents a scalable and economically attractive framework for optimizing COPD management by leveraging existing resources and technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.